Crossref journal-article
Elsevier BV
Molecular Pharmacology (78)
Bibliography

Perry, M., Stansfeld, P. J., Leaney, J., Wood, C., de Groot, M. J., Leishman, D., Sutcliffe, M. J., & Mitcheson, J. S. (2006). Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs. Molecular Pharmacology, 69(2), 509–519.

Authors 8
  1. Matthew Perry (first)
  2. Phillip J. Stansfeld (additional)
  3. Joanne Leaney (additional)
  4. Claire Wood (additional)
  5. Marcel J. de Groot (additional)
  6. Derek Leishman (additional)
  7. Michael J. Sutcliffe (additional)
  8. John S. Mitcheson (additional)
References 38 Referenced 73
  1. 10.1093/nar/28.1.235 / Nucleic Acids Res / The Protein Data Bank by Berman (2000)
  2. 10.1016/S0022-3565(25)24807-8 / J Pharmacol Exp Ther / Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog by Castle (1991)
  3. 10.1021/jm0208875 / J Med Chem / Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers by Cavalli (2002)
  4. 10.1073/pnas.192367299 / Proc Natl Acad Sci USA / Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels by Chen (2002)
  5. 10.1126/science.280.5360.69 / Science (Wash DC) / The structure of the potassium channel: molecular basis of K+ conduction and selectivity by Doyle (1998)
  6. 10.1124/jpet.301.2.427 / J Pharmacol Exp Ther / Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel by Ekins (2002)
  7. 10.1038/nrd1108 / Nat Rev Drug Disc / The impact of drug-induced QT interval prolongation on drug discovery and development by Fermini (2003)
  8. 10.1074/jbc.M310683200 / J Biol Chem / Physicochemical features of the HERG channel drug binding site by Fernandez (2004)
  9. 10.1124/mol.60.6.1343 / Mol Pharmacol / Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K+ channels by Ficker (2001)
  10. 10.1038/sj.bjp.0705025 / Br J Pharmacol / Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241 by Gessner (2003)
  11. 10.1124/mol.65.5.1120 / Mol Pharmacol / Molecular determinants for high-affinity block of human EAG potassium channels by antiarrhythmic agents by Gessner (2004)
  12. 10.1111/j.1469-7793.1998.003bi.x / J Physiol / Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels by Herzberg (1998)
  13. 10.1085/jgp.69.4.497 / J Gen Physiol / Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction by Hille (1977)
  14. 10.1016/0304-4157(77)90003-X / Biochim Biophys Acta / Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels by Hondeghem (1977)
  15. 10.1006/jmbi.1996.0897 / J Mol Biol / Development and validation of a genetic algorithm for flexible docking by Jones (1997)
  16. 10.1016/S0026-895X(24)23126-6 / Mol Pharmacol / Open channel block of HERG K+ channels by vesnarinone by Kamiya (2001)
  17. 10.1016/S0092-8674(01)00243-4 / Cell / Molecular and cellular mechanisms of cardiac arrhythmias by Keating (2001)
  18. 10.1016/S0026-895X(24)23209-0 / Mol Pharmacol / Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites by Lees-Miller (2000)
  19. 10.1038/sj.bjp.0705335 / Br J Pharmacol / Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 by Milnes (2003)
  20. 10.1073/pnas.210244497 / Proc Natl Acad Sci USA / A structural basis for drug-induced long QT syndrome by Mitcheson (2000)
  21. 10.1085/jgp.115.3.229 / J Gen Physiol / Trapping of a methanesulfonanilide by closure of the hERG potassium channel activation gate by Mitcheson (2000)
  22. {'key': '10.1124/mol.105.016741_bib22', 'first-page': '667', 'article-title': 'Molecular determinants of high-affinity drug binding to HERG channels', 'volume': '6', 'author': 'Mitcheson', 'year': '2003', 'journal-title': 'Curr Opin Drug Disc Dev'} / Curr Opin Drug Disc Dev / Molecular determinants of high-affinity drug binding to HERG channels by Mitcheson (2003)
  23. 10.1016/S0960-894X(03)00196-3 / Bioorg Med Chem Lett / Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches by Pearlstein (2003)
  24. 10.1124/mol.104.000117 / Mol Pharmacol / Structural determinants of HERG channel block by clofilium and ibutilide by Perry (2004)
  25. 10.1002/med.20019 / Med Res Rev / QT prolongation through hERG K+ channel blockade: current knowledge and strategies for the early prediction during drug development by Recanatini (2004)
  26. 10.1006/jmbi.1993.1626 / J Mol Biol / Comparative protein modelling by satisfaction of spatial restraints by Sali (1993)
  27. 10.1016/j.bbrc.2004.10.127 / Biochem Biophys Res Commun / High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656 by Ridley (2004)
  28. 10.1074/jbc.M200448200 / J Biol Chem / Molecular determinants of voltage dependent HERG K+ channel block by Sanchez-Chapula (2002)
  29. 10.1124/mol.63.5.1051 / Mol Pharmacol / Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain by Sanchez-Chapula (2003)
  30. 10.1016/0092-8674(95)90340-2 / Cell / A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel by Sanguinetti (1995)
  31. 10.1016/j.tips.2005.01.003 / Trends Pharmacol Sci / Predicting drug-hERG channel interactions that cause acquired long QT syndrome by Sanguinetti (2005)
  32. 10.1111/j.1469-7793.1999.667ad.x / J Physiol / Mutations of the S4–S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes by Sanguinetti (1999)
  33. 10.1016/S0006-3495(03)70020-4 / Biophys J / Sequence-function analysis of the K+-selective family of ion channels using a comprehensive alignment and the KcsA channel structure by Shealy (2003)
  34. 10.1161/01.RES.78.3.499 / Circ Res / Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides by Spector (1996)
  35. 10.1016/S0006-3495(01)75904-8 / Biophys J / Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds by Steidl (2001)
  36. 10.1016/S0014-5793(97)01030-2 / FEBS Lett / Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241 by Suessbrich (1997)
  37. 10.1006/jmcc.2000.1317 / J Mol Cell Cardiol / IKr: the hERG channel by Tseng (2001)
  38. 10.1016/S0165-6147(00)01662-X / Trends Pharmacol Sci / HERG K+ channels: friend and foe by Vandenberg (2001)
Dates
Type When
Created 19 years, 9 months ago (Nov. 16, 2005, 8:34 p.m.)
Deposited 6 months, 2 weeks ago (Feb. 19, 2025, 7 a.m.)
Indexed 1 month, 1 week ago (July 28, 2025, 2:52 a.m.)
Issued 19 years, 7 months ago (Feb. 1, 2006)
Published 19 years, 7 months ago (Feb. 1, 2006)
Published Print 19 years, 7 months ago (Feb. 1, 2006)
Funders 0

None

@article{Perry_2006, title={Drug Binding Interactions in the Inner Cavity of hERG Channels: Molecular Insights from Structure-Activity Relationships of Clofilium and Ibutilide Analogs}, volume={69}, ISSN={0026-895X}, url={http://dx.doi.org/10.1124/mol.105.016741}, DOI={10.1124/mol.105.016741}, number={2}, journal={Molecular Pharmacology}, publisher={Elsevier BV}, author={Perry, Matthew and Stansfeld, Phillip J. and Leaney, Joanne and Wood, Claire and de Groot, Marcel J. and Leishman, Derek and Sutcliffe, Michael J. and Mitcheson, John S.}, year={2006}, month=feb, pages={509–519} }